Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?

Alessandro Arrigo, Emanuela Aragona, Maurizio Battaglia Parodi, Francesco Loperfido, Francesco Bandello

Research output: Contribution to journalArticlepeer-review


SARS-CoV-2 infection recently reached pandemic proportions, with high risk of death for the worldwide population. In this dramatic scenario, all the resources are addressed to the intensive care units for the assessment of the emergency. However, more attention should be paid with respect to the risk of viral diffusion among asymptomatic people. Italy is the second most involved country in the world, and we needed to gain a lot of experience in a very limited time. At least 1 m of distance among people is recommended; however, some clinical practices cannot allow this distance. In this context, we believe that the careful safety assessment of clinical settings, like ophthalmologic ones, may have a remarkable impact on the fight against SARS-CoV-2 spread.

Original languageEnglish
Pages (from-to)1185-1187
Number of pages3
JournalEuropean Journal of Ophthalmology
Issue number5
Publication statusPublished - Sep 1 2020


  • cornea/external disease
  • COVID-19
  • eyelid disease: infections/inflammations
  • immunology
  • infectious diseases affecting lid/conjunctiva
  • preventive medicine/screening

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?'. Together they form a unique fingerprint.

Cite this